Is regression of left ventricular hypertrophy in maintenance hemodialysis patients possible?

Seminars in Dialysis

Volumn 21, Issue 5, 2008, Pages 422-430

  Bossola, Maurizio ^a   Tazza, Luigi ^a   Vulpio, Carlo ^a   Luciani, Giovanna ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT;

ARTICLE; CHRONIC KIDNEY FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY;

CARDIOVASCULAR AGENTS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 54749127781     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2008.00471.x     Document Type: Article

References (77)

1. London GM : Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 17 (Suppl. 1 29 36, 2002
2. London GM : Left ventricular hypertrophy: why does it happen? Nephrol Dial Transplant 18 (Suppl. 8 viii2 vii6, 2003
3. Middleton RJ, Parfrey PS, Foley R : Left ventricular hypertrophy in the renal patients. J Am Soc Nephrol 12 : 1079 1084, 2001
4. Silberberg JS, Barre P, Prichard S, Sniderman A : Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36 : 286 290, 1989
5. Foley RN, Parfrey PS, Kent GM, Harnett GD, Murray DC, Barre PE : Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int 54 : 1720 1725, 1998
6. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS : Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 65 : 1492 1498, 2004
7. Paoletti E, Specchia C, Di Maio G, Bellino D, Damasio B, Cassottana P, Canella G : The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 19 : 1829 1834, 2004
8. Parfrey PS, Harnett JD, Griffiths SM, Taylor R, Haud J, King A, Barre PE : The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 55 : 114 120, 1990
9. Hüting J, Kramer W, Schütterle G, Wizemann V : Analysis of left-ventricular changes associated with chronic hemodialysis. A non invasive follow-up study. Nephron 49 : 284 290, 1988
10. Foley RN, Parfrey PS, Morgan J, Barre PE, Campbell P, Cartier P, Coyle D, Fine A, Handa P, Kingma I, Lau CY, Levin A, Mendelssohn D, Muirhead N, Murphy B, Plante RK, Posen G, Wells GA : Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 58 : 1325 1335, 2000
11. Hayashi T, Suzuki A, Shoji T, Togawa M, Okada N, Tsubakihara Y, Imai E, Hori M : Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 35 : 250 256, 2000
12. Ayus JC, Go AS, Valderrabano F, Verde E, de Vineusa SG, Achinger SG, Lorenzo V, Arieff AI, Luño J Spanish Group for the Study of the Anemia and Left Ventricular Hypertrophy in Pre-dialysis Patients : Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dl. Kidney Int 68 : 788 795, 2005
13. Hassan K, Roguin N, Kaganov Y, Hasan S, Kristal B : Effect of erythropoietin therapy on red cells filterability and left ventricular mass in predialysis patients. Ren Fail 27 : 177 182, 2005
14. Pascual J, Teruel JL, Moya JL, Liaño F, Jiménez-Mena M, Ortuño J : Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol 35 : 280 287, 1991
15. Cannella G, La Canna G, Sandrini M, Gaggiotti M, Nordio G, Movilli E, Mombelloni S, Visioli O, Maiorca R : Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. Nephrol Dial Transplant 6 : 31 37, 1991
16. Rasić S, Kulenović I, Zulić I, et al. : The effect of erythropoietin treatment on left ventricular hypertrophy in haemodialysis patients. Bosn J Basic Med Sci 3 : 11 15, 2003
17. Blumberg A, Nelp WB, Hegstrom RM, Scribner BH : Extracellular volume in patients with chronic renal disease treated for hypertension by sodium restriction. Lancet 2 : 69 73, 1967
18. Rahman M, Fu P, Sehgal AR, Smith MC : Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis 35 : 257 265, 2000
19. Chen YC, Chen HH, Yeh JC, Chen SY : Adjusting dry weight by extracellular volume and body composition in hemodialysis patients. Nephron 92 : 91 96, 2002
20. Katzarski KS, Charra B, Luik AJ, Nisell J, Filho J, Leypoldt J, Leunissen K, Laurent G, Bergstrom J : Fluid state and blood pressure control in patients treated with long and short hemodialysis. Nephrol Dial Transplant 14 : 369 375, 1999
21. Charra B, Calemard B, Laurent G : Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 16 : 35 44, 1996
22. Fagugli RM, Pasini P, Quintaliani G, Pasticci F, Ciao G, Cicconi B, Ricciardi D, Santirosi PV, Buoncristiani E, Timio F, Valente F, Buoncristiani U : Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephrol Dial Transplant 18 : 2332 2338, 2003
23. Martin LC, Franco RJ, Gavras I, Matsubara BB, Garcia S, Caramori JT, Barretti BB, Balbi AL, Barsanti R, Padovani C, Gavras H : Association between hypervolemia and ventricular hypertrophy in hemodialysis patients. Am J Hypertens 17 : 1163 1169, 2004
24. Ozkahya M, Ok E, Cirit M, Aydin S, Akcicek F, Basci A, Dorhout Mees EJ : Regression of left ventricular hypertrophy in hemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 13 : 1489 1493, 1998
25. Chang ST, Chen CC, Chen CL, Cheng HW, Chung CM, Yang TY : Changes of the cardiac architectures and functions for chronic hemodialysis patients with dry weight determined by echocardiography Blood Purif 22 : 351 359, 2004
26. Gunal AI, Karaca I, Aygen B, Yavuzkir M, Dogukan A, Celiker H : Strict fluid volume control and left ventricular hypertrophy in hypertensive patients on chronic haemodialysis: a cross-sectional study. J Int Med Res 32 : 70 77, 2004
27. Jaeger JQ, Mehta RL : Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 10 : 392 403, 1999
28. Kouw PM, Kooman JP, Cheriex EC, Olthof CG, de Vries PMJM, Leunissen KML : Assessment of postdialysis dry weight: a comparison of techniques. J Am Soc Nephrol 4 : 98 104, 1993
29. Cheriex EC, Leunissen KML, Janssen JHA, Mooy JMV, Van Hoof JP : Echography of the inferior vena cava is a simple and reliable tool for estimation of "dry weight" in hemodialysis patients. Nephrol Dial Transplant 4 : 563 568, 1989
30. Lauster F, Gerzer R, Weil J, Fulle HJ, Schiff H : Assessment of dry body weight in hemodialysis patients by the biochemical marker cGMP. Nephrol Dial Transplant 5 : 356 361, 1990
31. Spiegel DM, Bashir K, Fish B : Bioimpedance resistance ratios for the evaluation of dry weight in hemodialysis. Clin Nephrol 53 : 108 114, 2000
32. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM : Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 327 : 669 677, 1992
33. The SOLVD Investigators : Effect of enalapril on survival. in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J med 325 : 293 302, 1991
34. Avanzini F, Ferrario G, Santoro L, Peci P, Giani P, Santoro E, Franzosi MG, Tognoni G Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardio-3 Investigators : Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: analysis of the GISSI-3 database. Am Heart J 144 : 1018 1025, 2002
35. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmkäi K, Dahlöf B, De Faire U, Mörlin C, Karlberg BE, Wester PO, Björck JE : Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 353 : 611 616, 1999
36. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G : Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 : 145 153, 2000
37. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S : Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the Hope randomized trial. Ann Int Med 134 : 629 636, 2001
38. Cannella G, Paoletti E, Delfino R, Peloso G, Molinari S, Traverso GB : Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 44 : 881 886, 1993
39. Roithinger FX, Punzengruber C, Wallner M, Ulbrich W, Pachinger O, Kramar R, Prischl FC : The influence of ACE-inhibition on myocardial mass and diastolic function in chronic hemodialysis patients with adequate control of blood pressure. Clin Nephrol 42 : 309 314, 1994
40. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL : Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 90 : 2786 2796, 1994
41. Wu SG, Lin SL, Wu CM, Jeng FR, Su CZ : Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients. Kaohsiung J Med Sci 15 : 62 68, 1999
42. Paoletti E, Cassottana P, Bellino D, Specchia C, Messa P, Cannella G : Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors. Am J Kidney Dis 40 : 728 736, 2002
43. Shibasaki Y, Masaki H, Nishiue T, Nishikawa M, Matsubara H, Iwasaka T : Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. Nephron 90 : 256 261, 2002
44. Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H, Suzuki H : Angiotensin receptor antagonist regresses left ventricular hypertrophy associated with diabetic nephropathy in dialysis patients. J Cardiovasc Pharmacol 43 : 380 386, 2004
45. Suzuki H, Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H : Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy. Ther Apher Dial 8 : 320 327, 2004
46. Nakayama M, Nakano H, Tsuboi N, Kurosawa T, Tsuruta Y, Iwasaki Y, Yokoyama K, Hosoya T, Fukagawa M : The effect of angiotensin receptor blockade ARB on the regression of left ventricular hypertrophy in hemodialysis patients: comparison between patients with D allele and non-D allele ACE gene polymorphism. Clin Nephrol 64 : 358 363, 2005
47. Canella G, Paoletti E, Delfino R, Peloso G, Rolla D, Molinari S : Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis 30 : 659 664, 1997
48. Yu WC, Lin YP, Lin IF, Chuang SY, Chen CH : Effect of ramipril on left ventricular mass in normotensive hemodialysis patients. Am J Kidney Dis 47 : 478 484, 2006
49. Matsumoto N, Ishimitsu T, Okamura A, Seta H, Takahashi M, Matsuoka H : Effects of imidapril on left ventricular mass in chronic hemodialysis patients. Hypertens Res 29 : 253 260, 2006
50. Suri RS, Nesrallah GE, Mainra R, Garg AX, Lindsay RM, Greene T, Daugirdas JT : Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol 1 : 33 42, 2006
51. Walsh M, Culleton B, Tonelli M, Manns B : A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 67 : 1500 1508, 2005
52. Buoncristiani U, Fagugli RM, Pinciaroli MR, Kulurianu H, Ceravolo G, Bova C : Reversal of left-ventricular hypertrophy in uremic patients by treatment with daily hemodialysis (DHD). Contrib Nephrol 119 : 152 156, 1996
53. Fagugli RM, Buoncristiani U, Ciao G : Anemia and blood pressure correction obtained by daily hemodialysis induce a reduction of left ventricular hypertrophy in dialysed patients. Int J Artif Organs 21 : 429 431, 1998
54. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U : Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 38 : 371 376, 2001
55. Fagugli RM, Pasini P, Pasticci F, Ciao G, Cicconi B, Buoncristiani U : Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study. J Nephrol 19 : 77 83, 2006
56. Chan CT, Floras JS, Miller JA, Richardson RMA, Pierratos A : Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61 : 2235 2239, 2002
57. Ayus JC, Reza Mizani M, Achinger SG, Thadhani R, Go AS, Lee S : Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol 16 : 2778 2788, 2005
58. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ : Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life. JAMA 298 : 1291 1299, 2007
59. Achinger SG, Ayus JC : Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor? J Am Soc Nephrol 17 : S255 S261, 2006
60. Galetta F, Cupisti A, Franzoni F, Femia FR, Rossi M, Barsotti G, Santoro G : Left ventricular function and calcium phosphate plasma levels in uremic patients. J Intern Med 258 : 378 384, 2005
61. Strozecki P, Adamowicz A, Nartowicz E, Odrowaz-Sypniewska G, Wlodarczyk Z, Manitius J : Parathormone, calcium, phosphorus and left ventricular structure and function in normotensive hemodialysis patients. Ren Fail 23 : 115 126, 2001
62. Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen Y-S, Rigor DL, Stillman I, Tamez H, Kroeger PE, Wu-Wong RR, Karumanchi A, Thadhani R, Kang PM : Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A 104 : 16810 16815, 2007
63. Nibbelink KA, Tishkoff DX, Hershey SD, Rahman A, Simpson RU : 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol 103 : 533 537, 2007
64. Wu J, Garami M, Cheng T, Gardner DG : 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 97 : 1577 1588, 1996
65. Gonzales EA, Sachdeva A, Oliver DA, Martin KJ : Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24 : 503 510, 2004
66. Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR : Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodialysis Int 11 : 315 321, 2007
67. Holick MF : Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79 : 362 371, 2004
68. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P : Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure. J Am Coll Cardiol 41 : 105 112, 2003
69. Kristal-Boneh E, Froom P, Harari G, Ribak J : Association of calcitriol and blood pressure in normotensive men. Hypertension 30 : 1289 1294, 1997
70. Harkness L, Cromer B : Low levels of 25-hydroxyvitamin D are associated with elevated parathyroid hormone in healthy adolescent females. Osteoporos Int 16 : 109 113, 2005
71. Lemmila S, Saha H, Virtanen V, Ala-Houahala I, Pasternack A : Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Am J Nephrol 18 : 404 410, 1998
72. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Choi EJ, Chang YS, Bang BK : Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 33 : 73 81, 1999
73. Kim HW, Park CW, Shin YS, Kim YS, Shin SJ, Kim YS, Choi EJ, Chang YS, Bang BK : Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis. Nephron Clin Pract 102 : c21 c29, 2006
74. Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen Y-S, Rigor DL, Stillman I, Tamez H, Kroeger PE, Wu-Wong RR, Karumanchi A, Thadhani R, Kang PM : Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Nat Acad Sci U S A 104 : 16810 16815, 2007
75. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME : Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12 : 2759 2767, 2001
76. Hampl H, Hennig L, Gogoll L : Regression of Left Ventricular Hypertrophy (LVH) in Diabetic Patients Receiving Chronic Hemodialysis (HD). The American Society of Nephrology Renal Week, San Francisco October 31-November 5, 2007 [Abstract SA-PO 1030]
77. Kutlay S, Dincer I, Sengul S, Nergizoglu G, Duman N, Erturk S : The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients. Am J Kidney Dis 47 : 485 492, 2006